National Center for Biotechnology Information
Preventable cancers
United states of America
The proposed innovation involves bioengineering of extracellular vesicles (EVs) and cells derived from patients hence allowing the designing of ad hoc systems and univocal targeting strategies. Extracellular vesicles (EVs) are classified in two categories based on their biogenesis. This paper has a summary of some key studies.